These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 28394882

  • 1. miR-4417 Targets Tripartite Motif-Containing 35 (TRIM35) and Regulates Pyruvate Kinase Muscle 2 (PKM2) Phosphorylation to Promote Proliferation and Suppress Apoptosis in Hepatocellular Carcinoma Cells.
    Song L, Zhang W, Chang Z, Pan Y, Zong H, Fan Q, Wang L.
    Med Sci Monit; 2017 Apr 10; 23():1741-1750. PubMed ID: 28394882
    [Abstract] [Full Text] [Related]

  • 2. Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma.
    Chen Z, Lu X, Wang Z, Jin G, Wang Q, Chen D, Chen T, Li J, Fan J, Cong W, Gao Q, He X.
    Oncotarget; 2015 Feb 10; 6(4):2538-48. PubMed ID: 25576919
    [Abstract] [Full Text] [Related]

  • 3. TRIM35 Interacts with pyruvate kinase isoform M2 to suppress the Warburg effect and tumorigenicity in hepatocellular carcinoma.
    Chen Z, Wang Z, Guo W, Zhang Z, Zhao F, Zhao Y, Jia D, Ding J, Wang H, Yao M, He X.
    Oncogene; 2015 Jul 23; 34(30):3946-56. PubMed ID: 25263439
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-122 affects cell aggressiveness and apoptosis by targeting PKM2 in human hepatocellular carcinoma.
    Xu Q, Zhang M, Tu J, Pang L, Cai W, Liu X.
    Oncol Rep; 2015 Oct 23; 34(4):2054-64. PubMed ID: 26252254
    [Abstract] [Full Text] [Related]

  • 5. miR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma.
    Liu AM, Xu Z, Shek FH, Wong KF, Lee NP, Poon RT, Chen J, Luk JM.
    PLoS One; 2014 Oct 23; 9(1):e86872. PubMed ID: 24466275
    [Abstract] [Full Text] [Related]

  • 6. Switching of pyruvate kinase isoform L to M2 promotes metabolic reprogramming in hepatocarcinogenesis.
    Wong CC, Au SL, Tse AP, Xu IM, Lai RK, Chiu DK, Wei LL, Fan DN, Tsang FH, Lo RC, Wong CM, Ng IO.
    PLoS One; 2014 Oct 23; 9(12):e115036. PubMed ID: 25541689
    [Abstract] [Full Text] [Related]

  • 7. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
    Xu Q, Tu J, Dou C, Zhang J, Yang L, Liu X, Lei K, Liu Z, Wang Y, Li L, Bao H, Wang J, Tu K.
    Mol Cancer; 2017 Dec 20; 16(1):178. PubMed ID: 29262861
    [Abstract] [Full Text] [Related]

  • 8. LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.
    Jia G, Wang Y, Lin C, Lai S, Dai H, Wang Z, Dai L, Su H, Song Y, Zhang N, Feng Y, Tang B.
    J Exp Clin Cancer Res; 2021 Sep 22; 40(1):299. PubMed ID: 34551796
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
    Zhao G, Wang T, Huang QK, Pu M, Sun W, Zhang ZC, Ling R, Tao KS.
    World J Gastroenterol; 2016 Jun 21; 22(23):5364-73. PubMed ID: 27340352
    [Abstract] [Full Text] [Related]

  • 10. PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma.
    Liu WR, Tian MX, Yang LX, Lin YL, Jin L, Ding ZB, Shen YH, Peng YF, Gao DM, Zhou J, Qiu SJ, Dai Z, He R, Fan J, Shi YH.
    Oncotarget; 2015 Jan 20; 6(2):846-61. PubMed ID: 25514599
    [Abstract] [Full Text] [Related]

  • 11. Oviductus ranae protein hydrolysate (ORPH) inhibits the growth, metastasis and glycolysis of HCC by targeting miR-491-5p/PKM2 axis.
    Xu Q, Dou C, Liu X, Yang L, Ni C, Wang J, Guo Y, Yang W, Tong X, Huang D.
    Biomed Pharmacother; 2018 Nov 20; 107():1692-1704. PubMed ID: 30257387
    [Abstract] [Full Text] [Related]

  • 12. MiR-103 regulates hepatocellular carcinoma growth by targeting AKAP12.
    Xia W, Ni J, Zhuang J, Qian L, Wang P, Wang J.
    Int J Biochem Cell Biol; 2016 Feb 20; 71():1-11. PubMed ID: 26646106
    [Abstract] [Full Text] [Related]

  • 13. Role of miR-193a-5p in the proliferation and apoptosis of hepatocellular carcinoma.
    Wang JT, Wang ZH.
    Eur Rev Med Pharmacol Sci; 2018 Nov 20; 22(21):7233-7239. PubMed ID: 30468466
    [Abstract] [Full Text] [Related]

  • 14. MiR-107 suppresses proliferation of hepatoma cells through targeting HMGA2 mRNA 3'UTR.
    Wang Y, Chen F, Zhao M, Yang Z, Zhang S, Ye L, Gao H, Zhang X.
    Biochem Biophys Res Commun; 2016 Nov 18; 480(3):455-460. PubMed ID: 27773820
    [Abstract] [Full Text] [Related]

  • 15. miR-493-5p suppresses hepatocellular carcinoma cell proliferation through targeting GP73.
    Zhao J, Xu T, Wang F, Cai W, Chen L.
    Biomed Pharmacother; 2017 Jun 18; 90():744-751. PubMed ID: 28419971
    [Abstract] [Full Text] [Related]

  • 16. Pyruvate kinase M2 prevents apoptosis via modulating Bim stability and associates with poor outcome in hepatocellular carcinoma.
    Hu W, Lu SX, Li M, Zhang C, Liu LL, Fu J, Jin JT, Luo RZ, Zhang CZ, Yun JP.
    Oncotarget; 2015 Mar 30; 6(9):6570-83. PubMed ID: 25788265
    [Abstract] [Full Text] [Related]

  • 17. miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1).
    Zhu Q, Gong L, Wang J, Tu Q, Yao L, Zhang JR, Han XJ, Zhu SJ, Wang SM, Li YH, Zhang W.
    BMC Cancer; 2016 Oct 18; 16(1):806. PubMed ID: 27756250
    [Abstract] [Full Text] [Related]

  • 18. MiR-3174 promotes proliferation and inhibits apoptosis by targeting FOXO1 in hepatocellular carcinoma.
    Wang Q, Yang X, Zhou X, Wu B, Zhu D, Jia W, Chu J, Wang J, Wu J, Kong L.
    Biochem Biophys Res Commun; 2020 Jun 11; 526(4):889-897. PubMed ID: 32279994
    [Abstract] [Full Text] [Related]

  • 19. microRNA-141 inhibits cell proliferation and invasion and promotes apoptosis by targeting hepatocyte nuclear factor-3β in hepatocellular carcinoma cells.
    Lin L, Liang H, Wang Y, Yin X, Hu Y, Huang J, Ren T, Xu H, Zheng L, Chen X.
    BMC Cancer; 2014 Nov 25; 14():879. PubMed ID: 25425543
    [Abstract] [Full Text] [Related]

  • 20. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.
    Chen L, Guan H, Gu C, Cao Y, Shao J, Wang F.
    Tumour Biol; 2016 Feb 25; 37(2):2497-507. PubMed ID: 26385772
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.